Showing 61–68 of 68 results

Palivizumab

394,00 

Therapeutic RSV protein F-antibody from the original Synagis commercial drug targeting the RSV protein F-antigen, also referred to as Synagis antibody.

Rituximab

169,00 

Therapeutic CD20-antibody from the original Mabthera commercial drug targeting the CD20-antigen, also referred to as Mabthera antibody.

Daratumumab

198,00 558,00 

Therapeutic CD38-antibody from the original Darzalex commercial drug targeting the CD38-antigen, also referred to as Darzalex antibody.

Ramucirumab

144,00 

Therapeutic VEGFR2-antibody from the original Cyramza commercial drug targeting the VEGFR2-antigen, also referred to as Cyramza antibody.

Bevacizumab

151,00 185,00 

Therapeutic VEGF-A-antibody from the original Avastin commercial drug targeting the VEGF-A-antigen, also referred to as Avastin antibody.

Avastin TEST

151,00 185,00 

Therapeutic VEGF-A-antibody from the original Avastin commercial drug targeting the VEGF-A-antigen, also referred to as Avastin antibody.

Secukinumab

525,00 

Therapeutic IL 17A-antibody from the original Cosentyx commercial drug targeting the IL 17A-antigen, also referred to as Cosentyx antibody.

Trastuzumab

245,00 

Therapeutic HER2-antibody from the original Herceptin commercial drug targeting the HER2-antigen, also referred to as Trastuzumab antibody.